UCB Clinical Pharma Scholarship

UCB Pharma Australia offers an annual scholarship to the Epilepsy Society of Australia to fund the salary of a young physician undertaking specialised training in epilepsy. The scholarship, valued at $65,000, is tenable at any Australian teaching hospital for a maximum of 12 months.

Applications will be evaluated by the Education Subcommittee of the ESA.

The Scholarship will presented each year at the ESA Annual Scientific Meeting (ASM).

To be eligible, the applicant must:

  • Be resident in Australia at the time of application.
  • Be 40 years of age or younger at the time of taking up the scholarship.
  • Be a medical graduate who has completed the core component of advanced training in general medicine, neurology, paediatrics, clinical pharmacology or other medical specialty relevant to epilepsy.
  • Have demonstrated clinical excellence and the capacity to undertake specialised epilepsy training.
  • Intend to continue a career in epilepsy in Australia.
  • Be a member of the ESA.

The application must include:

  • An accompanying letter in support of the application from the principal supervisor or the institution where the applicant intends to undertake epilepsy training.
  • A curriculum vitae.
  • A summary of the training program.
  • The names of two referees.

Please state on your application if you have applied for funding elsewhere. Candidates may obtain up to 50% of the UCB Phama Scholarship amount from another source to top up a full time salary.

Applications for the scholarship should be forwarded to the ESA secretariat by email to enquiries@epilepsy-society.org.au. The closing date for applications is August 31, 2018. Applicants will be advised of the outcome as soon as possible after this date.

To read about past recipients of this scholarship and their training programs, visit the Past Recipients section of this website.